Position in AMGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$121,479,731
+$9,389,149 QoQ
Shares Held
345,260
+0.8% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $1,375,333,185 across 16 Drug Manufacturers - General names. AMGN ranks #5 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
345,970 | $318,212,826 | |
| 2 | JNJ |
Johnson & Johnson
|
1,034,600 | $252,897,624 | |
| 3 | ABBV |
AbbVie Inc.
|
965,429 | $209,971,153 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,193,872 | $143,610,862 | |
| 5 | AMGN |
Amgen Inc
This page
|
345,260 | $121,479,731 | |
| 6 | PFE |
Pfizer Inc
|
3,213,627 | $90,238,646 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
404,797 | $56,416,557 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
822,948 | $49,911,796 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,479,731 | 345,260 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $112,090,582 | 342,460 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $91,869,363 | 325,547 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $62,346,476 | 223,296 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $70,478,529 | 226,219 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $52,104,542 | 199,910 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $64,409,456 | 199,899 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $63,348,612 | 202,748 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $66,354,317 | 233,379 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $18,223,313 | 63,271 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $17,255,735 | 64,205 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,556,319 | 61,059 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $13,585,624 | 56,197 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,961,417 | 53,158 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,890,123 | 74,934 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,876,969 | 44,706 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $10,292,826 | 42,564 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,735,360 | 38,829 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,916,321 | 37,227 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,776,325 | 40,108 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,287,396 | 29,289 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,293,214 | 36,070 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $574,147 | 2,259 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $542,006 | 2,298 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $475,199 | 2,344 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||